This is tailored to each patients needs and involves regular check-ins with doctors
N Engl J Med 384(12):11131124 Polyzos SA, Kountouras J, Zavos C, Deretzi G (2012) Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit disease
Biomarker contextincluding fasting glucose, HbA1c, lipid profile, and inflammatory markerscan support a provider conversation about whether GLP-1 therapy aligns with overall metabolic health goals alongside musculoskeletal relief
While most people associate antioxidants with immune health or skin, the lungs are one of the organs that depend on glutathione most heavily
Who should not use Ozempic
A new study is investigating whether higher doses of injectable GLP-1 agonist Trulicity (dulaglutide) are more effective